Singapore markets closed

Penumbra, Inc. (PEN)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
200.23-1.21 (-0.60%)
At close: 04:00PM EDT
200.23 0.00 (0.00%)
After hours: 05:49PM EDT

Penumbra, Inc.

One Penumbra Place
Alameda, CA 94502
United States
510 748 3200

IndustryMedical Devices
Full-time employees4,200

Key executives

NameTitlePayExercisedYear born
Mr. Adam ElsesserCo-Founder, Chairman, President & CEO601.62k16.27M1962
Dr. Arani Bose M.D.Co-Founder & Director54kN/A1962
Ms. Maggie S. YuenChief Financial Officer666.04kN/A1972
Mr. Lambert ShiuChief Accounting Officer539.94k579.45k1980
Ms. Johanna RobertsExecutive VP, General Counsel & Secretary661.89k1.08M1972
Mr. Ben SorciExecutive Vice President of OperationsN/AN/AN/A
Mr. Pankaj TiwariExecutive VP & Chief Information OfficerN/AN/AN/A
Ms. Jee Hamlyn-HarrisInvestor Relations OfficerN/AN/AN/A
Mr. Ben TompkinsExecutive Vice President of DevelopmentN/AN/AN/A
Ms. Gita BarryPresident of Immersive HealthcareN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Corporate governance

Penumbra, Inc.’s ISS governance QualityScore as of 1 May 2024 is 7. The pillar scores are Audit: 9; Board: 6; Shareholder rights: 7; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.